IP Library Granted Patent US 10,293,084
Granted Patent B2
US 10,293,084 · App. 14/685,714 · Granted May 21, 2019

Extracellular matrix (ECM) structures for tissue regeneration

Inventor: Robert G. Matheny (Norcross, GA)
Assignee: Aziyo Med, LLC
A61L27/54A61F2/02A61K35/12A61K35/28A61K38/18A61K38/1825A61L27/3629A61L27/3633A61L27/3641A61L27/3679A61L27/3804A61L27/3839A61L31/005A61F2/24A61F2210/0076A61K35/22A61K35/38A61K38/005C07K14/435C12N5/068
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,293,084
App. No.
14/685,714
Granted
May 21, 2019
Kind
B2
Abstract

An extracellular matrix (ECM) structure for tissue regeneration, the ECM structure having a a sheet member comprising small intestine submucosa (SIS), the SIS sheet member being folded and laminated proximate the sheet member edge, wherein a folded laminated ECM structure having a cavity therein is formed, the ECM structure further including an ECM composition that is disposed in the ECM structure cavity, the ECM composition including liver basement membrane, urinary bladder submucosa, a mesenchymal stem cell and a growth factor.

Claims (27)

1. An implantable medical product, comprising:

a bioremodelable pouch structure comprising an extracellular matrix (ECM) structure in sheet form, said ECM structure comprising acellular ECM from a decellularized mammalian tissue source, said decellularized mammalian tissue source being small intestine submucosa, liver basement membrane, stomach submucosa, urinary bladder submucosa, placental basement membrane, pancreatic basement membrane, large intestine submucosa, lung interstitial membrane, respiratory tract submucosa, heart extracellular matrix, or dermal matrix;

said pouch structure comprising an internal cavity having an opening, wherein the pouch structure is configured to contain an additional component or composition in the internal cavity;

wherein the ECM structure provides tensile strength to support newly forming tissue and includes first and second ECM sheets or sheet portions, each ECM sheet or sheet portion having single or plural layers and edges, wherein only the edges of the ECM sheets or sheet portions are joined together by laminating, suturing or gluing except for the edges that form the opening to provide the internal cavity that is located between the sheets or sheet portions;

wherein the composition provided in the internal cavity of the pouch structure comprises an antibiotic or a drug or a biologically active agent,

wherein the pouch structure effectively improves biological functions by promoting tissue regeneration, modulated healing of adjacent tissue or growth of new tissue when implanted in a body of a warm blooded mammal.

2. The product of claim 1 , wherein the edges are joined together by suturing.

3. The product of claim 1 , wherein the pouch structure has a rectangular configuration with one closed end and only the edges of both sides of the ECM sheet portions adjacent the closed end are joined together.

4. The product of claim 1 , wherein the composition contained in the internal cavity comprises cells or a protein as the biologically active agent.

5. The product of claim 1 , wherein the composition contained in the internal cavity is a biologically active agent.

6. The product of claim 1 , wherein the composition contained in the internal cavity is a gelatinous semi-solid or powder material.

7. The product of claim 6 , wherein the edges are partially joined so that the composition can ooze out from the internal cavity.

8. The product of claim 1 , wherein the pouch has a periphery that is round.

9. The product of claim 1 , wherein the pouch has a periphery that is generally rectangular.

10. The product of claim 1 , wherein each ECM sheet includes 2 or 3 layers of SIS material.

11. The product of claim 1 , wherein the edges are completely laminated or joined together.

12. The product of claim 1 , wherein the pouch structure has a rectangular configuration with one closed end and only the edges of both sides adjacent the closed end are joined together, and with the composition contained in the internal cavity of the pouch structure comprising an antibiotic or a drug or a biologically active agent.

13. The product of claim 1 , wherein the pouch structure has a round configuration and the composition contained in the internal cavity comprises an antibiotic or a drug or a biologically active agent.

14. The product of claim 13 , wherein the additional composition in the internal cavity of the pouch structure is in the form of a gelatinous semi-solid or powder material, wherein the edges are partially joined so that the material can ooze out from the internal cavity.

15. An implantable medical product, comprising:

a bioremodelable pouch structure comprising an extracellular matrix (ECM) structure in sheet form, said ECM structure comprising acellular ECM from a decellularized mammalian tissue source, said decellularized mammalian tissue source being small intestine submucosa, liver basement membrane, stomach submucosa, urinary bladder submucosa, placental basement membrane, pancreatic basement membrane, large intestine submucosa, lung interstitial membrane, respiratory tract submucosa, heart extracellular matrix, or dermal matrix;

said pouch structure comprising an internal cavity and an opening, wherein the pouch structure is configured to receive and contain an additional component or composition in the internal cavity;

wherein the ECM structure provides tensile strength to support newly forming tissue and includes first and second ECM sheets or sheet portions, each ECM sheet or sheet portion having single or plural layers and edges, wherein only the edges of the ECM sheets or sheet portions are joined together by laminating, suturing or gluing except for the edges that form the opening to provide the internal cavity that is located between the sheets or sheet portions;

wherein the composition provided in the internal cavity of the pouch structure effectively improves biological functions by promoting tissue regeneration, modulated healing of adjacent tissue or growth of new tissue when implanted in a body of a warm blooded mammal.

16. The product of claim 15 , wherein the edges are joined together by suturing.

17. The product of claim 15 , wherein each ECM sheet is made of 2 or 3 layers of ECM material and the pouch structure has a periphery that is round.

18. The product of claim 15 , wherein each ECM sheet is made of 2 or 3 layers of ECM material and the pouch structure is generally rectangular.

Assignments (14)
RELEASE OF SECURITY INTEREST Recorded Oct 3, 2025
From: SWK FUNDING LLC
To: ELUTIA INC. (F/K/A AZIYO BIOLOGICS, INC.); ELUTIA MED LLC (F/K/A AZIYO MED, LLC)
Reel/Frame 072468/0896 →
CHANGE OF NAME Recorded Sep 15, 2023
From: AZIYO BIOLOGICS, INC.
To: ELUTIA INC.
Reel/Frame 064923/0361 →
CHANGE OF NAME Recorded Sep 15, 2023
From: AZIYO MED, LLC
To: ELUTIA MED LLC
Reel/Frame 064923/0704 →
SECURITY INTEREST Recorded Aug 12, 2022
From: AZIYO BIOLOGICS, INC.; AZIYO MED, LLC
To: SWK FUNDING LLC
Reel/Frame 060792/0045 →
RELEASE OF SECURITY INTEREST Recorded Aug 12, 2022
From: AZIYO BIOLOGICS, INC.; AZIYO MED, LLC
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061161/0001 →
RELEASE OF SECURITY INTEREST Recorded Aug 12, 2022
From: AZIYO BIOLOGICS, INC.; AZIYO MED, LLC
To: MIDCAP FUNDING IV TRUST
Reel/Frame 061164/0532 →
REAFFIRMATION & AMENDMENT TO SECURITY INTEREST (TERM) Recorded Jul 24, 2019
From: AZIYO BIOLOGICS, INC.; AZIYO MED, LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 049842/0132 →
REAFFIRMATION & AMENDMENT TO SECURITY INTEREST (REVOLVING) Recorded Jul 24, 2019
From: AZIYO BIOLOGICS, INC.; AZIYO MED, LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 049842/0107 →
SEURITY INTEREST (TERM) Recorded Aug 2, 2017
From: AZIYO BIOLOGICS, INC.; AZIYO MED, LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 043413/0942 →
SECURITY INTEREST (REVOLVING) Recorded Aug 2, 2017
From: AZIYO BIOLOGICS, INC.; AZIYO MED, LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 043414/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2017
From: CORMATRIX CARDIOVASCULAR, INC.
To: AZIYO MED, LLC
Reel/Frame 042577/0126 →
RELEASE OF SECURITY INTEREST Recorded Jun 2, 2017
From: MIDCAP FINANCIAL TRUST
To: CORMATRIX CARDIOVASCULAR, INC.
Reel/Frame 042669/0559 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2016
From: MATHENY, ROBERT G
To: CORMATRIX CARDIOVASCULAR, INC.
Reel/Frame 039414/0325 →
SECURITY INTEREST Recorded Sep 30, 2015
From: CORMATRIX CARDIOVASCULAR, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 036732/0103 →
Continuity (5)
Continuation 14306368 · Jun 17, 2014
Continuation 13033102 · Feb 23, 2011
Continuation 12394914 · Feb 27, 2009
Continuation 11747004 · May 10, 2007
Related Publication 20150217026A1 · Aug 6, 2015
Cited By (1)
US 12,514,958